6wgl: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "6wgl" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 6wgl is ON HOLD | The entry 6wgl is ON HOLD until Paper Publication | ||
Authors: Druzina, Z., Atwell, S., Pustilnik, A., Antonysamy, S., Ho, C., Lieu, R., Hendle, J., Benach, J., Wang, J. | Authors: Druzina, Z., Atwell, S., Pustilnik, A., Antonysamy, S., Ho, C., Lieu, R., Hendle, J., Benach, J., Wang, J. | ||
Description: Dupilumab- | Description: Dupilumab fab with Crystal Kappa design complexed with human IL-4 receptor | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
[[Category: Hendle, J]] | [[Category: Hendle, J]] | ||
Revision as of 04:14, 22 April 2020
Unreleased structure
The entry 6wgl is ON HOLD until Paper Publication
Authors: Druzina, Z., Atwell, S., Pustilnik, A., Antonysamy, S., Ho, C., Lieu, R., Hendle, J., Benach, J., Wang, J.
Description: Dupilumab fab with Crystal Kappa design complexed with human IL-4 receptor
